Depot Medroxyprogesterone Acetate Injection Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Depot Medroxyprogesterone Acetate Injection Market: By Type (Prescriptions, Generic Prescriptions), By Application (Contraceptive, Hormone Replacement Therapy, Treatment of Endometriosis, Others), By End User (Hospital, Pharmacy, Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Depot medroxyprogesterone acetate injection is a contraceptive injection. It is similar to the hormone called progesterone, which is produced in the body by the ovaries. The contraceptive injection mainly works by stopping the ovaries from releasing an egg (ovulation). The contraceptive injections are much more effective than oral one. Their effectiveness ranges from 94% to 99%. These injections are taken after every twelve week time period. However, lack of resources such as trained nurses or healthcare professionals and infrastructure to administer injectable contraceptives in several developing and underdeveloped countries may hinder the growth of the market over forecast period. Also, availability of alternative contraceptive methods such as condoms, IUCDs, oral contraceptives may also restrain the market growth.

Notable Market Developments

The Pfizer Inc., collaborated with the Bill & Melinda Gates Foundation, and the Children’s Investment Fund Foundation (CIFF) to broaden the access to Pfizer’s all-in-one injectable contraceptive “Sayana Press” which will be available to qualified purchasers at a guaranteed price of US $0.85 per dose, to help the females in poor countries.

Depot Medroxyprogesterone Acetate Injection Market

MARKET SUMMARY
-
x%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– x%
  • Largest Market– North-America
  • Fastest Growing Market– Asia-Pacific

Depot Medroxyprogesterone Acetate Injection Market

  • The depot medroxyprogesterone acetate injection market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The depot medroxyprogesterone acetate injection market is segmented based on product type, end user, and geography.
Key Players
  • Pfizer
  • Amphastar Pharmaceuticals, Inc.
  • Teva Pharmaceuticals
  • Mylan Laboratories
Depot Medroxyprogesterone Acetate Injection Market

DRIVERS AND RESTRAINTS

The factors which are streaming the growth of this market are growing awareness among urban young woman, who are intended postpone pregnancy, increase in disposable income in developing countries and growing middle class population in emerging countries, and increasing collaboration between public, private, and non-governmental organization effectively helping to improve the access to medication in resource constrained and underdeveloped countries.


North-America Got Significant Share

Depot Medroxyprogesterone Acetate Injection Market

North America dominates the global depot medroxyprogesterone acetate injection market followed by Europe. However, Asia Pacific and Africa markets are projected to grow with a high CAGR owing to increase in awareness about the advanced methods of contraception and active involvement of government and NGO agencies to promote advanced methods of contraception.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Depot Medroxyprogesterone Acetate Injection Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Executive Summary
2. Global Depot Medroxyprogesterone Acetate Injection Market Introduction
2.1. Global Depot Medroxyprogesterone Acetate Injection Market– Taxonomy
2.2. Global Depot Medroxyprogesterone Acetate Injection Market–Definitions
2.2.1. By Type
2.2.2. By End User
2.2.3. By Application
2.2.4. By Region
3. Global Depot Medroxyprogesterone Acetate Injection Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Depot Medroxyprogesterone Acetate Injection Market Dynamic Factors – Impact Analysis
3.6. Global Depot Medroxyprogesterone Acetate Injection Market– Competition Landscape
4. Global Depot Medroxyprogesterone Acetate Injection Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Hand Tools Market, By Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Prescriptions
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028  (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Generic Prescriptions
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Hand Tools Market, By End User, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1. Hospital
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028  (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Pharmacy
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028  (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Others
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028  (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Depot Medroxyprogesterone Acetate Injection Market Forecast, By Application, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1. Contraceptives
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028  (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Hormone Replacement Therapy
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028  (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Treatment of Endometriosis
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028  (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028  (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Depot Medroxyprogesterone Acetate Injection Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028  (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028  (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028  (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028  (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028  (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Depot Medroxyprogesterone Acetate Injection Market – Opportunity Analysis Index, By Type, By End User, By Application and Region, 2022 – 2028
9. North America Depot Medroxyprogesterone Acetate Injection Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.  Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Prescriptions
9.1.2. Generic Prescriptions
9.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Hospital
9.2.2. Pharmacy
9.2.3. Others
9.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Contraceptive
9.3.2. Hormone Replacement Therapy
9.3.3. Treatment of Endometriosis
9.3.4. Others
9.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Depot Medroxyprogesterone Acetate Injection Market – Opportunity Analysis Index, By Type, By End User, By Application and Country, 2022 – 2028
9.6. North America Depot Medroxyprogesterone Acetate Injection Market Dynamics – Trends
10. Europe Depot Medroxyprogesterone Acetate Injection Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1.  Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Prescriptions
10.1.2. Generic Prescriptions
10.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Hospital
10.2.2. Pharmacy
10.2.3. Others
10.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Contraceptive
10.3.2. Hormone Replacement Therapy
10.3.3. Treatment of Endometriosis
10.3.4. Others
10.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Rest of Europe
10.5. Europe Depot Medroxyprogesterone Acetate Injection Market – Opportunity Analysis Index, By Type, By End User, By Application and Country, 2022 – 2028
10.6. Europe Depot Medroxyprogesterone Acetate Injection Market Dynamics – Trends
11. Asia-Pacific Depot Medroxyprogesterone Acetate Injection Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1.  Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Prescriptions
11.1.2. Generic Prescriptions
11.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Hospital
11.2.2. Pharmacy
11.2.3. Others
11.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Contraceptive
11.3.2. Hormone Replacement Therapy
11.3.3. Treatment of Endometriosis
11.3.4. Others
11.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. China
11.4.2. India
11.4.3. Japan
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Depot Medroxyprogesterone Acetate Injection Market – Opportunity Analysis Index, By Type, By End User, By Application and Country, 2022 – 2028
11.6. Asia-Pacific Depot Medroxyprogesterone Acetate Injection Market Dynamics – Trends
12. Latin America Depot Medroxyprogesterone Acetate Injection Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Prescriptions
12.1.2. Generic Prescriptions
12.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Hospital
12.2.2. Pharmacy
12.2.3. Others
12.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Contraceptive
12.3.2. Hormone Replacement Therapy
12.3.3. Treatment of Endometriosis
12.3.4. Others
12.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Depot Medroxyprogesterone Acetate Injection Market – Opportunity Analysis Index, By Type, By End User, By Application and Country, 2022 – 2028
12.6. Latin America Depot Medroxyprogesterone Acetate Injection Market Dynamics – Trends
13. Middle East and Africa Depot Medroxyprogesterone Acetate Injection Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1.  Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Prescriptions
13.1.2. Generic Prescriptions
13.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Hospital
13.2.2. Pharmacy
13.2.3. Others
13.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Contraceptive
13.3.2. Hormone Replacement Therapy
13.3.3. Treatment of Endometriosis
13.3.4. Others
13.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Depot Medroxyprogesterone Acetate Injection Market – Opportunity Analysis Index, By Type, By End User, By Application and Country, 2022 – 2028
13.6. MEA Depot Medroxyprogesterone Acetate Injection Market Dynamics – Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Pfizer Inc.
14.2.2. Fangtong Pharma.Co. Ltd
14.2.3. Gador S.A.
14.2.4. Sigma-Aldrich Co. LLC.
14.2.5. Teva Pharmaceutical Industries Ltd.
14.2.6. Greenstone LLC
14.2.7. Serum Internation Ltd.
14.2.8. West-Coast Pharmaceutical
14.2.9. Arrow Pharma Group,
14.2.10. Zuche Pharmaceuticals Pvt. Ltd.
15. Research Methodology
16. Key Assumptions and Acronyms

Report

Company Profile

  • Pfizer Inc.
  • Fangtong Pharma.Co. Ltd
  • Gador S.A.
  • Sigma-Aldrich Co. LLC.
  • Teva Pharmaceutical Industries Ltd.
  • Greenstone LLC
  • Serum Internation Ltd.
  • West-Coast Pharmaceutical
  • Arrow Pharma Group,
  • Zuche Pharmaceuticals Pvt. Ltd.

Description

Depot medroxyprogesterone acetate injection is a contraceptive injection. It is similar to the hormone called progesterone, which is produced in the body by the ovaries. The contraceptive injection mainly works by stopping the ovaries from releasing an egg (ovulation). The contraceptive injections are much more effective than oral one. Their effectiveness ranges from 94% to 99%. These injections are taken after every twelve week time period. However, lack of resources such as trained nurses or healthcare professionals and infrastructure to administer injectable contraceptives in several developing and underdeveloped countries may hinder the growth of the market over forecast period. Also, availability of alternative contraceptive methods such as condoms, IUCDs, oral contraceptives may also restrain the market growth.

Notable Market Developments

The Pfizer Inc., collaborated with the Bill & Melinda Gates Foundation, and the Children’s Investment Fund Foundation (CIFF) to broaden the access to Pfizer’s all-in-one injectable contraceptive “Sayana Press” which will be available to qualified purchasers at a guaranteed price of US $0.85 per dose, to help the females in poor countries.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX